Status:
UNKNOWN
A Comparison of Safety and Immunogenicity of Rabies Pre Exposure Prophylaxis Regimen Between Gvt of India Approved and WHO Approved.
Lead Sponsor:
Kempegowda Institute of Medical Sciences, Bangalore
Conditions:
Vaccine Reaction
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to compare WHO recommended PrEP Vaccination Schedule, 2 doses 0.2ml 2 sites (0.1ml each site) on day 0 and day 7 and Government of India currently recommended PrEP S...
Detailed Description
The study will be conducted among healthy adult volunteers visiting the Anti Rabies Clinic, Preventive Medicine Unit, Kempegowda Institute of Medical Sciences Hospital\& Research Centre, Bangalore and...
Eligibility Criteria
Inclusion
- Healthy subjects willing to volunteer and sign written informed consent for the study.
- Subjects should be available for the follow-up period.
Exclusion
- Received Anti rabies vaccine or RIG or RMAb anytime in the past.
- Participation in any other clinical trial in the past three months.
- Severely immunocompromised subjects, pregnant and lactating women.
- Subjects with known history of allergy.
Key Trial Info
Start Date :
April 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT06066294
Start Date
April 3 2023
End Date
November 1 2024
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kempegowda Institute Of Medical Sciences Hospital and Research Center
Bengaluru, Karnataka, India, 560002